Company intelligence / Profile preview

Calmare Therapeutics

Fairfield, Connecticut, United Statescalmaretherapeutics.com ↗

Ownership: Private
Development stage: Other

Overview

The company’s flagship product, the Calmare Pain Therapy Device, has FDA clearance and CE-mark for commercial sale. It provides non-invasive, non-addictive treatment for chronic and neuropathic pain with demonstrated efficacy in outpatient settings. The device has been adopted by U.S. military hospitals and clinics and awarded a multi-year federal supply contract.[1][5] Clinical results have shown benefit in conditions such as chemotherapy-induced peripheral neuropathy and complex regional pain syndrome.[1]

Therapeutic areas: DermatologyNeurologyOncology
Modalities: DeviceNon-pharmacological therapyNeurostimulation device
Industry: Therapeutic Medical Devices

Partnerships

U.S. Department of Veterans Affairs (federal supply contract)[5]

Beyond the preview

Go deeper on Calmare Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calmare Therapeutics.

Explore the full profile